| For: | Lakatos PL, Kiss LS. Is the disease course predictable in inflammatory bowel diseases? World J Gastroenterol 2010; 16(21): 2591-2599 [PMID: 20518079 DOI: 10.3748/wjg.v16.i21.2591] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i21/2591.htm |
| Number | Citing Articles |
| 1 |
Marieke Smink, Frederik K Lotgering, Lisette Albers, Dirk J de Jong. Effect of childbirth on the course of Crohn's disease; results from a retrospective cohort study in the Netherlands. BMC Gastroenterology 2011; 11(1) doi: 10.1186/1471-230X-11-6
|
| 2 |
Dominika Głąbska, Dominika Guzek, Barbara Kanarek, Gustaw Lech. Analysis of Association between Dietary Intake and Red Blood Cell Count Results in Remission Ulcerative Colitis Individuals. Medicina 2019; 55(4) doi: 10.3390/medicina55040096
|
| 3 |
Lajos Sandor Kiss, Maria Papp, Barbara Dorottya Lovasz, Zsuzsanna Vegh, Petra Anna Golovics, Eszter Janka, Eva Varga, Miklos Szathmari, Peter Laszlo Lakatos. High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohnʼs disease: A marker for patient classification?. Inflammatory Bowel Diseases 2012; 18(9) doi: 10.1002/ibd.21933
|
| 4 |
Renáta Bor, Klaudia Farkas, Anita Bálint, Mónika SzŰcs, Szabolcs Ábrahám, Gellért Baradnay, Tibor Wittmann, Zoltán Szepes, Ferenc Nagy, Tamás Molnár. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn’s disease – clinical observations from a tertiary Eastern European center. Scandinavian Journal of Gastroenterology 2015; 50(2) doi: 10.3109/00365521.2014.936033
|
| 5 |
L. S. Kiss, T. Szamosi, T. Molnar, P. Miheller, L. Lakatos, A. Vincze, K. Palatka, Z. Barta, B. Gasztonyi, A. Salamon, G. Horvath, G. T. Tóth, K. Farkas, J. Banai, Z. Tulassay, F. Nagy, M. Szenes, G. Veres, B. D. Lovasz, Z. Vegh, P. A. Golovics, M. Szathmari, M. Papp, P. L. Lakatos. Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease. Alimentary Pharmacology & Therapeutics 2011; 34(8) doi: 10.1111/j.1365-2036.2011.04827.x
|
| 6 |
Margaret S. Bynoe, Adam T. Waickman, Deeqa A. Mahamed, Cynthia Mueller, Jeffrey H. Mills, Agnieszka Czopik. CD73 Is Critical for the Resolution of Murine Colonic Inflammation. Journal of Biomedicine and Biotechnology 2012; 2012 doi: 10.1155/2012/260983
|
| 7 |
Roy Frei, Nicolas Fournier, Jonas Zeitz, Michael Scharl, Bernhard Morell, Thomas Greuter, Philipp Schreiner, Benjamin Misselwitz, Ekaterina Safroneeva, Alain M Schoepfer, Stephan R Vavricka, Gerhard Rogler, Luc Biedermann. Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn’s Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study. Journal of Crohn's and Colitis 2019; 13(10) doi: 10.1093/ecco-jcc/jjz057
|
| 8 |
Lajos Sándor Kiss, Tamás Szamosi, Tamás Molnár, Pál Miheller, László Lakatos, Áron Vincze, Károly Palatka, Zsolt Bartha, Beáta Gasztonyi, Ágnes Salamon, Gábor Horváth, Gábor Tamás Tóth, Klaudia Farkas, János Banai, Zsolt Tulassay, Ferenc Nagy, Mária Szenes, Gábor Veres, Barbara Dorottya Lovász, Zsuzsanna Végh, Petra Anna Golovics, Miklós Szathmári, Mária Papp, Péter László Lakatos. Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn’s disease. National data from Hungary. Orvosi Hetilap 2011; 152(36) doi: 10.1556/OH.2011.29200
|
| 9 |
Ren Mao, Yun Qiu, Bai-Li Chen, Sheng-Hong Zhang, Rui Feng, Yao He, Zhi- Rong Zeng, Shomron Ben-Horin, Min-Hu Chen. Factors associated with the achievement of mucosal healing in Crohn’s disease: the benefit of endoscopic monitoring in treating to target. Therapeutic Advances in Gastroenterology 2017; 10(6) doi: 10.1177/1756283X17698089
|
| 10 |
Dominika Głąbska, Aleksandra Kołota, Katarzyna Lachowicz, Dominika Skolmowska, Małgorzata Stachoń, Dominika Guzek. Vitamin D Supplementation and Mental Health in Inflammatory Bowel Diseases and Irritable Bowel Syndrome Patients: A Systematic Review. Nutrients 2021; 13(10) doi: 10.3390/nu13103662
|